Twenty-five-year experience with ventricular septal defect in infants and children

American Heart Journal
|September 1, 1987
PubMed

Insights

Small and moderate ventricular septal defects (VSDs) in children often resolve without surgery. Large VSDs may require intervention, but many close spontaneously, indicating a good prognosis with proper management.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Ventricular Septal Defects (VSDs) are common congenital heart abnormalities.
  • Understanding VSD natural history is crucial for appropriate management.

Purpose of the Study:

  • To analyze the long-term outcomes of isolated VSDs based on defect size.
  • To evaluate the need for surgical intervention in different VSD categories.

Main Methods:

  • Retrospective analysis of 381 children with isolated VSDs catheterized between 1960-1985.
  • Defect size categorized by right-to-left ventricular systolic pressure ratio.
  • Serial catheterizations used to assess VSD progression and pulmonary artery pressures.

Main Results:

  • Small VSDs generally had good outcomes without pulmonary vascular disease.
  • 75% of moderate VSDs did not require surgery; 58% showed normal pulmonary artery pressures on follow-up.
  • Large-restrictive VSDs were less likely to require surgery in infancy compared to nonrestrictive VSDs (12% vs 51%).
  • Many VSDs, particularly large-restrictive types, demonstrated spontaneous closure or decrease in size.

Conclusions:

  • Surgery is infrequently necessary for small and moderate VSDs in the first year of life due to spontaneous improvement.
  • Large-restrictive VSDs often decrease in size, with many patients avoiding surgery.
  • Nonrestrictive VSDs have an excellent prognosis with appropriate clinical management.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...